- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02105402
Treatment Efficacy for Developmental Motor Speech Disorders
Treatment Efficacy for Developmental Motor Speech Disorders: A PROMPT Randomized Control Trial
The purpose of this study is to carry out a high-level treatment efficacy study on children with speech sound disorders with motor speech involvement (SSD-MSI) using a well-controlled Randomized Controlled Trial design.
The intervention of choice is the Prompts for Restructuring Oral Muscular Phonetic Targets (PROMPT) approach, which has been effective in treating motor speech disorders in adults and in children with autism and cerebral palsy.
Study Overview
Status
Intervention / Treatment
Detailed Description
The results of this study will allow us to determine if there is a causal relationship between PROMPT treatment and outcome measures and predict how much improvement can be expected from this therapy. This study is being conducted as a part of a multicenter clinical trial in the province of Ontario, Canada with three sites: The John McGivney Children's Centre in Windsor, The ErinoakKids Centre for Treatment and Development in Mississauga, and The Speech and Stuttering Institute in Toronto.
The study integrity will be monitored by an arms-length, external agency, The Applied Health Research Centre (AHRC) at St. Michael's Hospital in Toronto. The study is coordinated by the Department of Speech-Language Pathology at the University of Toronto and funded by the PROMPT Institute in Santa Fe, New Mexico.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Mississauga, Ontario, Canada, L5K 2N6
- ErinoakKids Centre for Treatment and Development
-
Toronto, Ontario, Canada, M3B 3J5
- The Speech and Stuttering Institute
-
Windsor, Ontario, Canada, N9C 4C2
- The John McGivney Children's Centre of Essex County
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The child is between 3 and 10 Years.
- English is the primary language spoken by the primary caregiver at home.
- Hearing/Vision (corrected is acceptable- e.g., spectacles) is within normal limits.
- Readiness for direct speech therapy.
- Age appropriate social interaction and play skills.
- Age appropriate or mildly delayed receptive language skills.
- Normal to any amount of delay in expressive language development.
- Moderate to severe speech sound disorder.
- Age appropriate or slight delay non-verbal intelligence.
- 4 red flags for motor speech involvement.
Exclusion Criteria:
- Signs and symptoms suggesting global motor involvement (Cerebral Palsy).
- Signs and symptoms suggesting Autism Spectrum Disorders.
- Oral structural deficits.
- Feeding impairments.
- Signs of Dysarthric speech or significant drooling.
- Prosodic and / or resonance disorders.
- Diagnosis of Childhood Apraxia of Speech features
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Group - PROMPT therapy
Prompts for Restructuring Oral Muscular Phonetic Targets (PROMPT)
|
The PROMPT approach utilizes a motor-speech hierarchy (MSH) to guide speech language pathologists (SLP) in selecting speech movement goals for treatment.
PROMPT treatment generally proceeds systematically in a bottom-up fashion starting with the lowest subsystem in the hierarchy where a child has control issues.
Furthermore, in the PROMPT approach specific techniques are used to stimulate sensory input that are assumed to facilitate the formation of sensory-motor pathways required for the acquisition and accurate production of speech movement patterns.
As the speech motor behaviors are established, the clinician reduces the number of cues and the frequency and immediacy of feedback and practices transfer and generalization activities.
Other Names:
|
No Intervention: Waitlist or Delay Group
Participants in this group are on the waitlist for 10 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in speech motor control
Time Frame: At baseline and following 10 weeks of intervention or waitlist delay
|
Formal assessment of the neuromotor integrity of the motor speech system will be carried out using the verbal motor production assessment for children (VMPAC).
|
At baseline and following 10 weeks of intervention or waitlist delay
|
Change in speech articulation
Time Frame: At baseline and following 10 weeks of intervention or waitlist delay
|
Assessment of speech articulation will be carried out using the Diagnostic Evaluation of Articulation and Phonology (DEAP) test.
|
At baseline and following 10 weeks of intervention or waitlist delay
|
Change in word-level speech intelligibility
Time Frame: At baseline and following 10 weeks of intervention or waitlist delay
|
Word level assessment of speech intelligibility will be carried out using the Children's speech Intelligibility Measure.
|
At baseline and following 10 weeks of intervention or waitlist delay
|
Change in Functional Communication:
Time Frame: At baseline and following 10 weeks of intervention or waitlist delay
|
Focus on the Outcomes of Communication Under Six (FOCUS), is a parent questionnaire that captures preschool children's communication abilities as they participate in real-world situations.
|
At baseline and following 10 weeks of intervention or waitlist delay
|
Change in criterion-referenced measure of speech motor control.
Time Frame: At baseline and following 10 weeks of intervention or waitlist delay
|
Criterion-referenced assessment of the motor speech system will be carried out using a set of probe words.
The audio-video recordings of the probe words will be analyzed by three qualified and blinded speech language pathologists.
|
At baseline and following 10 weeks of intervention or waitlist delay
|
Change in phonological processes
Time Frame: At baseline and following 10 weeks of intervention or waitlist delay
|
Phonological processes will be assessed using the Diagnostic Evaluation of Articulation and Phonology (DEAP) test.
|
At baseline and following 10 weeks of intervention or waitlist delay
|
Change in sentence-level speech intelligibility
Time Frame: At baseline and following 10 weeks of intervention or waitlist delay
|
Sentence-level assessment of speech intelligibility will be carried out using the Beginner's Intelligibility Test.
|
At baseline and following 10 weeks of intervention or waitlist delay
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Aravind Namasivayam, Ph.D., University of Toronto
- Study Director: Deborah Hayden, M.A., The PROMPT Institute, Santa Fe, NM, 87505 USA
- Study Chair: Pascal van Lieshout, Ph.D., University of Toronto
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PROMPT-29142
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Randomized Controlled Trial for Speech Disorders in Children
-
American UniversityChildren's National Research InstituteCompletedRandomized Controlled Trial | Refractory Epilepsy | Diet Intervention | Epilepsy in Children | Epilepsy in YouthUnited States
-
University of BarcelonaNot yet recruitingAnxiety | Randomized Controlled Trial | Virtual Reality Exposure Therapy | AerophobiaSpain
-
Consorci Sanitari del MaresmeDepartment of Health, Generalitat de CatalunyaCompletedBorderline Personality Disorder | Randomized Controlled Trial
-
National Yang Ming UniversityTaipei Veterans General Hospital, TaiwanCompletedRandomized Controlled Trial
-
Universidad de ZaragozaCompletedMild Cognitive Impairment | Randomized Controlled Trial
-
Fundació Sant Joan de DéuCarlos III Health InstituteCompletedRandomized Controlled TrialSpain
-
National Yang Ming UniversityTri-Service General HospitalCompletedRandomized Controlled TrialTaiwan
-
Universidad de ZaragozaNot yet recruitingMild Cognitive Impairment | Randomized Controlled Trial | Subjective Cognitive Impairment
-
Dongzhimen Hospital, BeijingShanxi Zhendong Pharmacy Co., LtdCompletedRandomized Controlled Trial | Vascular Cognitive Impairment | Qi Zhi Tong Luo CapsuleChina
-
The Hong Kong Polytechnic UniversityCompletedCognitive Impairment | Executive Function | Efficacy | Schizophrenia; Psychosis | Randomized Controlled TrialHong Kong
Clinical Trials on PROMPT
-
University of CincinnatiRobert Wood Johnson FoundationCompleted
-
Virtua Health, Inc.Rutgers UniversityTerminated
-
Albert Einstein College of MedicineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedBreastfeeding | Breastfeeding, ExclusiveUnited States
-
Stanford UniversityRecruiting
-
St. Joseph's Healthcare HamiltonCompleted
-
University of PennsylvaniaCompletedBlood Pressure Check (Hypertension Screening) | Cholesterol Test (Lipid Disorder Screening)United States
-
University of California, Los AngelesNational Institutes of Health (NIH)RecruitingAutism Spectrum DisorderUnited States
-
University of RochesterRobert Wood Johnson Foundation; Halcyon Hill FoundationCompleted
-
Dartmouth-Hitchcock Medical CenterCystic Fibrosis FoundationCompletedChronic Disease | Cystic FibrosisUnited States
-
University of Texas at AustinCompletedMusculoskeletal DiseasesUnited States